More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.

Alzheimer's disease is the most common type of dementia. Here, we break down what to know about this disease, including: What ...

Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what this means for future treatment.

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

This has demonstrated the potential of palbociclib in treating Alzheimer’s disease,” Chen said. The research shows the drug ...

Diabetes, a chronic condition that affects millions of people, may have a connection with Alzheimer's disease. Unofficially ...

A new study finds that dementia cases are expected to double to 1 million by 2060, with African-American cases potentially ...

A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...

( MENAFN - JCN NewsWire) FDA Accepts LEQEMBI (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the treatment of Early Alzheimer's disease LEQEMBI is the only ...

"As anyone who has experienced a cancer diagnosis will know, it takes time to adjust to a new normal," the Princess of Wales ...

Israel Prize winner Prof. Michal Schwartz says her team's work fighting Alzheimer's can lead to treatments that boost immune ...

Frontotemporal dementia (FTD) is a rare and progressive form of dementia that primarily affects people between the ages of 40 ...